Clinical Trials Directory

Trials / Completed

CompletedNCT01853566

Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Universidade Federal do Rio de Janeiro · Academic / Other
Sex
Male
Age
50 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The growth hormone (GH) secretion declines gradually with age, with studies demonstrating a progressive reduction of 14% secretion per decade of life beginning in the second decade. Other studies suggest a disruption in GH secretion in elderly people. These findings suggest a possible association between growth hormone deficiency (GHD) and the ageing process.GH replacement is well known to improve body composition, leading to a decrease in total body fat and an increase in lean body mass. However, GH replacement has only shown an effect on muscle strength in GH-deficient adults subjected to long-term GH therapy. Few studies have evaluated the effect of GH replacement on muscle strength in elderly people engaged in a program of exercise training.Our purpose is to evaluate the effect of GH therapy on muscle strength in healthy, non-sedentary men over 50 years old.

Detailed description

At baseline, subjects are submitted to evaluation of GH secretion, testosterone level, body composition, and muscle strength. Absence of GHD and normal testosterone levels were necessary for the inclusion in the study. These parameters will be evaluated after 6 months of GH use x placebo.

Conditions

Interventions

TypeNameDescription
DRUGgrowth hormoneGH group intervention: use of GH - initial dose of 0.5 UI/day (0.2 mg/day), with readjustments to 1.0 UI/day (0.4 mg/day) and 1.5 UI/day (0.6 mg/day) after 1 and 2 months of treatment, respectively. The last GH dose will be maintained until the end of the study. These GH dosages were based on the dose used for adults of the same age with GHD. Subjects will be re-evaluated after 6 months of GH therapy or placebo according to muscle strength and body composition .The other group received placebo using the same scheme as the GH group.

Timeline

Start date
2012-01-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2013-05-15
Last updated
2014-09-03

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01853566. Inclusion in this directory is not an endorsement.